EUVIMEDEUVIMED entdecken
Leitlinie

Medical Practice Guidelines for Lung Cancers including malignant pleural mesotheliomas and thymic tumors according to evidence-based medicine. 2024. Edited by the Japan Lung Cancer Society. Chapter 3 Guidelines for thymic epithelial tumors – Summary of recommendations

Meinoshin Okumura, Kiminori Fujimoto, Nobuharu Hanaoka, Masahiko Kusumoto, Mitsugu Omasa, Hiroyuki Shiono, Noriyuki Tomiyama, Keita Kudo, Kayoko Tsujino, Keiji Nihei, Koichi Fukumoto, Yusuke Okuma und 6 weitere

Respiratory Investigation · 2025-11 · 63 (6) · 1115-1119

DOI: 10.1016/j.resinv.2025.09.005 ↗

Kurz gefasst

Leitlinie in der Zeitschrift Respiratory Investigation, 2025-11. Verfasst von Meinoshin Okumura und 17 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Thoracic Surgery, National Hospital Organization Osaka Toneyama Medical Center, Osaka, Japan. Electronic address: okumura.meino…. Hauptthemen laut MEDLINE: Thymus Neoplasms, Evidence-Based Medicine, Neoplasms, Glandular and Epithelial, Lung Neoplasms. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 9 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Japanese clinical guidelines for thymic epithelial tumors were initially presented by the Guidelines Committee of the Japan Lung Cancer Society (JLCS) in 2016. They are comprised of a set of evidence-based recommendations regarding clinical diagnosis, as well as treatment and pathological diagnosis of thymoma, thymic carcinoma, and thymic neuroendocrine tumor cases. Treatment recommendations are dependent on tumor stage and recurrence status, while treatment modalities include surgery, radiation therapy, chemotherapy, and multimodality therapy. Additionally, recommendations cover methods for handling resected specimens and consideration of essential contents for determining pathological diagnosis. Since the first version of the guidelines, there have been significant improvements in treatment options, including molecular target therapy, immune checkpoint inhibitor administration, and robotic surgery. In addition, a novel staging system using TNM classification of thymic epithelial tumor was established and approved by the Union of International Cancer Control in 2017. The JLCS performs annual reviews of the clinical guidelines for updating associated data and publishes a revised version biennially. The present report summarizes the most recent recommendations for treatment of thymic epithelial tumors, published in 2024.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Thymus NeoplasmsEvidence-Based MedicineNeoplasms, Glandular and EpithelialLung NeoplasmsMesothelioma, MalignantPleural NeoplasmsHumansJapanSocieties, MedicalNeoplasm StagingCombined Modality TherapyMolecular Targeted Therapy

Stichwörter der Autor:innen

DiagnosisThymic carcinomaThymic neuroendocrine tumorThymomaTreatment

Autor:innen und Institutionen

  • Department of General Thoracic Surgery, National Hospital Organization Osaka Toneyama Medical Center, Osaka, Japan. Electronic address: okumura.meinoshin.hy@mail.hosp.go.jp.
  • Department of Radiology, Kurume University School of Medicine, Fukuoka, Japan.
  • Department of Thoracic and Cardiovascular Surgery, Osaka Medical and Pharmaceutical University, Osaka, Japan.
  • Department of Diagnostic Radiology, National Cancer Center Hospital, Tokyo, Japan.
  • Department of Thoracic Surgery, Nishi-Kobe Medical Center, Hyogo, Japan.
  • Department of General Thoracic Surgery, Kindai University Nara Hospital, Nara, Japan.

Zitieren

APA

Okumura, M., Fujimoto, K., Hanaoka, N., Kusumoto, M., Omasa, M., Shiono, H., Tomiyama, N., Kudo, K., Tsujino, K., Nihei, K., Fukumoto, K., Okuma, Y., Takahashi, S., Takemoto, S., Funaki, S., Shimizu, S., Horiike, A., & Murakawa, T. (2025). Medical Practice Guidelines for Lung Cancers including malignant pleural mesotheliomas and thymic tumors according to evidence-based medicine. 2024. Edited by the Japan Lung Cancer Society. Chapter 3 Guidelines for thymic epithelial tumors – Summary of recommendations. Respiratory Investigation, 63(6), 1115-1119. https://doi.org/10.1016/j.resinv.2025.09.005

Vancouver

Okumura M, Fujimoto K, Hanaoka N, Kusumoto M, Omasa M, Shiono H, et al. Medical Practice Guidelines for Lung Cancers including malignant pleural mesotheliomas and thymic tumors according to evidence-based medicine. 2024. Edited by the Japan Lung Cancer Society. Chapter 3 Guidelines for thymic epithelial tumors – Summary of recommendations. Respiratory Investigation. 2025;63(6):1115-1119. doi:10.1016/j.resinv.2025.09.005

BibTeX
@article{Okumura2025,
  author = {Okumura, Meinoshin and Fujimoto, Kiminori and Hanaoka, Nobuharu and Kusumoto, Masahiko and Omasa, Mitsugu and Shiono, Hiroyuki and Tomiyama, Noriyuki and Kudo, Keita and Tsujino, Kayoko and Nihei, Keiji and Fukumoto, Koichi and Okuma, Yusuke and Takahashi, Shigeo and Takemoto, Shinnosuke and Funaki, Soichiro and Shimizu, Shigeki and Horiike, Atsushi and Murakawa, Tomohiro},
  title = {Medical Practice Guidelines for Lung Cancers including malignant pleural mesotheliomas and thymic tumors according to evidence-based medicine. 2024. Edited by the Japan Lung Cancer Society. Chapter 3 Guidelines for thymic epithelial tumors – Summary of recommendations},
  journal = {Respiratory Investigation},
  year = {2025},
  volume = {63},
  number = {6},
  pages = {1115--1119},
  doi = {10.1016/j.resinv.2025.09.005}
}
Kostenlos starten →